#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Long-Lived Antibody and B Cell Memory Responses to the Human Malaria Parasites, and


Antibodies constitute a critical component of the naturally acquired immunity that develops following frequent exposure to malaria. However, specific antibody titres have been reported to decline rapidly in the absence of reinfection, supporting the widely perceived notion that malaria infections fail to induce durable immunological memory responses. Currently, direct evidence for the presence or absence of immune memory to malaria is limited. In this study, we analysed the longevity of both antibody and B cell memory responses to malaria antigens among individuals who were living in an area of extremely low malaria transmission in northern Thailand, and who were known either to be malaria naïve or to have had a documented clinical attack of P. falciparum and/or P. vivax in the past 6 years. We found that exposure to malaria results in the generation of relatively avid antigen-specific antibodies and the establishment of populations of antigen-specific memory B cells in a significant proportion of malaria-exposed individuals. Both antibody and memory B cell responses to malaria antigens were stably maintained over time in the absence of reinfection. In a number of cases where antigen-specific antibodies were not detected in plasma, stable frequencies of antigen-specific memory B cells were nonetheless observed, suggesting that circulating memory B cells may be maintained independently of long-lived plasma cells. We conclude that infrequent malaria infections are capable of inducing long-lived antibody and memory B cell responses.


Vyšlo v časopise: Long-Lived Antibody and B Cell Memory Responses to the Human Malaria Parasites, and. PLoS Pathog 6(2): e32767. doi:10.1371/journal.ppat.1000770
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000770

Souhrn

Antibodies constitute a critical component of the naturally acquired immunity that develops following frequent exposure to malaria. However, specific antibody titres have been reported to decline rapidly in the absence of reinfection, supporting the widely perceived notion that malaria infections fail to induce durable immunological memory responses. Currently, direct evidence for the presence or absence of immune memory to malaria is limited. In this study, we analysed the longevity of both antibody and B cell memory responses to malaria antigens among individuals who were living in an area of extremely low malaria transmission in northern Thailand, and who were known either to be malaria naïve or to have had a documented clinical attack of P. falciparum and/or P. vivax in the past 6 years. We found that exposure to malaria results in the generation of relatively avid antigen-specific antibodies and the establishment of populations of antigen-specific memory B cells in a significant proportion of malaria-exposed individuals. Both antibody and memory B cell responses to malaria antigens were stably maintained over time in the absence of reinfection. In a number of cases where antigen-specific antibodies were not detected in plasma, stable frequencies of antigen-specific memory B cells were nonetheless observed, suggesting that circulating memory B cells may be maintained independently of long-lived plasma cells. We conclude that infrequent malaria infections are capable of inducing long-lived antibody and memory B cell responses.


Zdroje

1. GuptaS

SnowRW

DonnellyCA

MarshK

NewboldC

1999 Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med 5 340 343

2. WipasaJ

ElliottS

XuH

GoodMF

2002 Immunity to asexual blood stage malaria and vaccine approaches. Immunol Cell Biol 80 401 414

3. BeesonJG

OsierFH

EngwerdaCR

2008 Recent insights into humoral and cellular immune responses against malaria. Trends Parasitol 24 578 584

4. LanghorneJ

NdunguFM

SponaasAM

MarshK

2008 Immunity to malaria: more questions than answers. Nat Immunol 9 725 732

5. StruikSS

RileyEM

2004 Does malaria suffer from lack of memory? Immunol Rev 201 268 290

6. StephensR

AlbanoFR

QuinS

PascalBJ

HarrisonV

2005 Malaria-specific transgenic CD4(+) T cells protect immunodeficient mice from lethal infection and demonstrate requirement for a protective threshold of antibody production for parasite clearance. Blood 106 1676 1684

7. D'Imperio LimaMR

AlvarezJM

FurtadoGC

KipnisTL

CoutinhoA

1996 Ig-isotype patterns of primary and secondary B cell responses to Plasmodium chabaudi chabaudi correlate with IFN-gamma and IL-4 cytokine production with CD45RB expression by CD4+ spleen cells. Scand J Immunol 43 263 270

8. WykesMN

ZhouYH

LiuXQ

GoodMF

2005 Plasmodium yoelii can ablate vaccine-induced long-term protection in mice. J Immunol 175 2510 2516

9. CarvalhoLJ

Ferreira-da-CruzMF

Daniel-RibeiroCT

Pelajo-MachadoM

LenziHL

2007 Germinal center architecture disturbance during Plasmodium berghei ANKA infection in CBA mice. Malar J 6 59

10. TaylorRR

EganA

McGuinnessD

JepsonA

AdairR

1996 Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting. Int Immunol 8 905 915

11. UdhayakumarV

KariukiS

KolczackM

GirmaM

RobertsJM

2001 Longitudinal study of natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII. Am J Trop Med Hyg 65 100 107

12. DrakeleyCJ

CorranPH

ColemanPG

TongrenJE

McDonaldSL

2005 Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Proc Natl Acad Sci U S A 102 5108 5113

13. CavanaghDR

ElhassanIM

RoperC

RobinsonVJ

GihaH

1998 A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan. J Immunol 161 347 359

14. DorfmanJR

BejonP

NdunguFM

LanghorneJ

KortokMM

2005 B cell memory to 3 Plasmodium falciparum blood-stage antigens in a malaria-endemic area. J Infect Dis 191 1623 1630

15. AkpoghenetaOJ

DuahNO

TettehKK

DunyoS

LanarDE

2008 Duration of naturally acquired antibody responses to blood-stage Plasmodium falciparum is age dependent and antigen specific. Infect Immun 76 1748 1755

16. AsitoAS

MoormannAM

KiprotichC

Ng'ang'aZW

Ploutz-SnyderR

2008 Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children. Malar J 7 238

17. KumarN

FolgarJP

LubegaP

1992 Recognition of Plasmodium falciparum asexual stage antigens by antibodies in sera from people exposed to Plasmodium vivax. Am J Trop Med Hyg 47 422 428

18. JangpatarapongsaK

SirichaisinthopJ

SattabongkotJ

CuiL

MontgomerySM

2006 Memory T cells protect against Plasmodium vivax infection. Microbes Infect 8 680 686

19. ZeveringY

KhamboonruangC

RungruengthanakitK

TungviboonchaiL

RuengpipattanapanJ

1994 Life-spans of human T-cell responses to determinants from the circumsporozoite proteins of Plasmodium falciparum and Plasmodium vivax. Proc Natl Acad Sci U S A 91 6118 6122

20. IgonetS

Vulliez-Le NormandB

FaureG

RiottotMM

KockenCH

2007 Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation. J Mol Biol 366 1523 1537

21. BrachoC

PerezH

1992 An immunocytochemical test for the diagnosis of antibodies to Plasmodium vivax. Parasite Immunol 14 481 487

22. KimYM

HwangHA

YunWS

KimSI

LeeKW

2004 Efficacy of the merozoite surface protein 1 of Plasmodium vivax as an antigen for ELISA to diagnose malaria. Yonsei Med J 45 129 134

23. PhanTG

PausD

ChanTD

TurnerML

NuttSL

2006 High affinity germinal center B cells are actively selected into the plasma cell compartment. J Exp Med 203 2419 2424

24. AdamsCL

MacleodMK

James Milner-WhiteE

AitkenR

GarsideP

2003 Complete analysis of the B-cell response to a protein antigen, from in vivo germinal centre formation to 3-D modelling of affinity maturation. Immunology 108 274 287

25. CrottyS

FelgnerP

DaviesH

GlidewellJ

VillarrealL

2003 Cutting edge: long-term B cell memory in humans after smallpox vaccination. J Immunol 171 4969 4973

26. LanghorneJ

CrossC

SeixasE

LiC

von der WeidT

1998 A role for B cells in the development of T cell helper function in a malaria infection in mice. Proc Natl Acad Sci U S A 95 1730 1734

27. PierceSK

MillerLH

2009 World Malaria Day 2009: what malaria knows about the immune system that immunologists still do not. J Immunol 182 5171 5177

28. KinyanjuiSM

BullP

NewboldCI

MarshK

2003 Kinetics of antibody responses to Plasmodium falciparum-infected erythrocyte variant surface antigens. J Infect Dis 187 667 674

29. PihlgrenM

FriedliM

TougneC

RochatAF

LambertPH

2006 Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival. J Immunol 176 165 172

30. PihlgrenM

SchallertN

TougneC

BozzottiP

KovarikJ

2001 Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life. Eur J Immunol 31 939 946

31. StephensR

NdunguFM

LanghorneJ

2009 Germinal centre and marginal zone B cells expand quickly in a second Plasmodium chabaudi malaria infection producing mature plasma cells. Parasite Immunol 31 20 31

32. The Ministry of Public Health, Thailand 2003 Manual for Malaria Control; Bureau of Vector Borne Diseases, editor Bangkok The Agricultural Co-operative Federation of Thailand., Limited

33. Department of Disease Control, The Minstry of Public Health. Report on malaria cases. http://203.157.41.98/malaria/freereoprt/rep.php?free=1&PHPSESSID=368625f72ed8fbe6801903db82d4c152

34. ClutterbuckEA

OhS

HamalubaM

WestcarS

BeverleyPC

2008 Serotype-specific and age-dependent generation of pneumococcal polysaccharide-specific memory B-cell and antibody responses to immunization with a pneumococcal conjugate vaccine. Clin Vaccine Immunol 15 182 193

35. BuismanAM

de RondCG

OzturkK

Ten HulscherHI

van BinnendijkRS

2009 Long-term presence of memory B-cells specific for different vaccine components. Vaccine 28 179 86

36. ManzRA

HauserAE

HiepeF

RadbruchA

2005 Maintenance of serum antibody levels. Annu Rev Immunol 23 367 386

37. AmannaIJ

CarlsonNE

SlifkaMK

2007 Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 357 1903 1915

38. HopkinsRJ

KramerWG

BlackwelderWC

AshtekarM

HagueL

2004 Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteers. Clin Infect Dis 39 759 766

39. BensonMJ

ElguetaR

SchperoW

MolloyM

ZhangW

2009 Distinction of the memory B cell response to cognate antigen versus bystander inflammatory signals. J Exp Med 206 2013 25

40. BernasconiNL

TraggiaiE

LanzavecchiaA

2002 Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298 2199 2202

41. MontesCL

Acosta-RodriguezEV

MerinoMC

BermejoDA

GruppiA

2007 Polyclonal B cell activation in infections: infectious agents' devilry or defense mechanism of the host? J Leukoc Biol 82 1027 1032

42. MuehlinghausG

CiglianoL

HuehnS

PeddinghausA

LeyendeckersH

2005 Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood 105 3965 3971

43. TokoyodaK

EgawaT

SugiyamaT

ChoiBI

NagasawaT

2004 Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 20 707 718

44. CromptonPD

MirceticM

WeissG

BaughmanA

HuangCY

2009 The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals. J Immunol 182 3318 3326

45. AlwaynIP

XuY

BaskerM

WuC

BuhlerL

2001 Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody. Xenotransplantation 8 157 171

46. DiLilloDJ

HamaguchiY

UedaY

YangK

UchidaJ

2008 Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. J Immunol 180 361 371

47. AnolikJH

BarnardJ

CappioneA

Pugh-BernardAE

FelgarRE

2004 Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum 50 3580 3590

48. VallerskogT

GunnarssonI

WidheM

RisseladaA

KlareskogL

2007 Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE. Clin Immunol 122 62 74

49. Bouharoun-TayounH

AttanathP

SabchareonA

ChongsuphajaisiddhiT

DruilheP

1990 Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes. J Exp Med 172 1633 1641

50. PierceSK

2009 Understanding B cell activation: from single molecule tracking, through Tolls, to stalking memory in malaria. Immunol Res 43 85 97

51. ThimasarnK

JatapadmaS

VijaykadgaS

SirichaisinthopJ

WongsrichanalaiC

1995 Epidemiology of Malaria in Thailand. J Travel Med 2 59 65

52. SnounouG

ViriyakosolS

ZhuXP

JarraW

PinheiroL

1993 High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 61 315 320

53. BurghausPA

HolderAA

1994 Expression of the 19-kilodalton carboxy-terminal fragment of the Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol Biochem Parasitol 64 165 169

54. TragerW

JensenJB

1976 Human malaria parasites in continuous culture. Science 193 673 675

55. EganAF

ChappelJA

BurghausPA

MorrisJS

McBrideJS

1995 Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum. Infect Immun 63 456 466

56. VyseAJ

GayNJ

HeskethLM

PebodyR

Morgan-CapnerP

2006 Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiol Infect 134 1303 1312

57. OhumaEO

OkiroEA

BettA

AbwaoJ

WereS

2009 Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models. Epidemiol Infect 137 227 233

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 2
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#